Six (25%) cases of loss of heterozygosity were revealed, among which 5 (83.3%) cases of loss of heterozygosity were detected by the sequencing method in DLBCL tissue samples with mutations in exons 5–8 and adjacent intron regions of the TP53 gene. The gene discussed is TP53; the disease is diffuse large B-cell lymphoma.